{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T02:37:06Z","timestamp":1792204626954,"version":"4.4.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["atherosclerosis-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.atherosclerosis.2013.03.038","type":"journal-article","created":{"date-parts":[[2013,4,22]],"date-time":"2013-04-22T11:18:16Z","timestamp":1366629496000},"page":"192-197","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["Increased lysophosphatidic acid levels in culprit coronary arteries of\u00a0patients with acute coronary syndrome"],"prefix":"10.1016","volume":"229","author":[{"given":"Tomotaka","family":"Dohi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsumi","family":"Miyauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryunosuke","family":"Ohkawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Kurano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Kishimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naotake","family":"Yanagisawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manabu","family":"Ogita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihisa","family":"Nishino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Yaginuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiko","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Kurata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Daida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Yatomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2013.03.038_bib1","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1002\/jcb.20108","article-title":"Thrombogenic and atherogenic activities of lysophosphatidic acid","volume":"92","author":"Siess","year":"2004","journal-title":"J\u00a0Cell Biochem"},{"key":"10.1016\/j.atherosclerosis.2013.03.038_bib2","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1159\/000093222","article-title":"Platelet interaction with bioactive lipids formed by mild oxidation of low-density lipoprotein","volume":"35","author":"Siess","year":"2006","journal-title":"Pathophysiol Haemost Thromb"},{"key":"10.1016\/j.atherosclerosis.2013.03.038_bib3","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.tcm.2009.07.005","article-title":"Blood relatives: dynamic regulation of bioactive lysophosphatidic acid and sphingosine-1-phosphate metabolism in the circulation","volume":"19","author":"Morris","year":"2009","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.atherosclerosis.2013.03.038_bib4","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/S1388-1981(02)00173-7","article-title":"Athero- and thrombogenic actions of lysophosphatidic acid and sphingosine-1-phosphate","volume":"1582","author":"Siess","year":"2002","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.atherosclerosis.2013.03.038_bib5","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1476-5381.2012.02021.x","article-title":"Lysophosphatidic acid in atherosclerotic diseases","volume":"167","author":"Schober","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.atherosclerosis.2013.03.038_bib6","doi-asserted-by":"crossref","first-page":"48737","DOI":"10.1074\/jbc.M206812200","article-title":"Serum lysophosphatidic acid is produced through diverse phospholipase pathways","volume":"277","author":"Aoki","year":"2002","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2013.03.038_bib7","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.2353\/ajpath.2010.090009","article-title":"Atherosclerotic lesion progression changes lysophosphatidic acid homeostasis to favor its accumulation","volume":"176","author":"Bot","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.atherosclerosis.2013.03.038_bib8","doi-asserted-by":"crossref","first-page":"6931","DOI":"10.1073\/pnas.96.12.6931","article-title":"Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions","volume":"96","author":"Siess","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.atherosclerosis.2013.03.038_bib9","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.bbalip.2008.05.008","article-title":"Roles of lysophosphatidic acid in cardiovascular physiology and disease","volume":"1781","author":"Smyth","year":"2008","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.atherosclerosis.2013.03.038_bib10","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s11239-011-0577-6","article-title":"The role of PGE(2) in human atherosclerotic plaque on platelet EP(3) and EP (4) receptor activation and platelet function in whole blood","volume":"32","author":"Schober","year":"2011","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.atherosclerosis.2013.03.038_bib11","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.cca.2011.09.027","article-title":"Increased circulating plasma lysophosphatidic acid in patients with acute coronary syndrome","volume":"413","author":"Dohi","year":"2012","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.atherosclerosis.2013.03.038_bib12","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1161\/CIRCULATIONAHA.107.188209","volume":"117","author":"Antman","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2013.03.038_bib13","doi-asserted-by":"crossref","first-page":"e148","DOI":"10.1161\/CIRCULATIONAHA.107.181940","volume":"116","author":"Anderson","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2013.03.038_bib14","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0009-8981(03)00165-7","article-title":"A\u00a0novel colorimetric assay for the determination of lysophosphatidic acid in plasma using an enzymatic cycling method","volume":"333","author":"Kishimoto","year":"2003","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.atherosclerosis.2013.03.038_bib15","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ab.2007.05.004","article-title":"Suppression of lysophosphatidic acid and lysophosphatidylcholine formation in the plasma in\u00a0vitro: proposal of a plasma sample preparation method for laboratory testing of these lipids","volume":"367","author":"Nakamura","year":"2007","journal-title":"Anal Biochem"},{"key":"10.1016\/j.atherosclerosis.2013.03.038_bib16","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0009-9120(02)00327-2","article-title":"An enzymatic assay for lysophosphatidylcholine concentration in human serum and plasma","volume":"35","author":"Kishimoto","year":"2002","journal-title":"Clin Biochem"},{"key":"10.1016\/j.atherosclerosis.2013.03.038_bib17","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cca.2007.10.005","article-title":"Validation of an autotaxin enzyme immunoassay in human serum samples and its application to hypoalbuminemia differentiation","volume":"388","author":"Nakamura","year":"2008","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.atherosclerosis.2013.03.038_bib18","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1258\/acb.2008.007242","article-title":"Measurement of plasma lysophosphatidic acid concentration in healthy subjects: strong correlation with lysophospholipase D activity","volume":"45","author":"Hosogaya","year":"2008","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.atherosclerosis.2013.03.038_bib19","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0009-8981(00)00216-3","article-title":"Spectrophotometric assay for serum platelet-activating factor acetylhydrolase activity","volume":"296","author":"Kosaka","year":"2000","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.atherosclerosis.2013.03.038_bib20","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1194\/jlr.M013326","article-title":"The phospholipase A1 activity of lysophospholipase A-I links platelet activation to LPA production during blood coagulation","volume":"52","author":"Bolen","year":"2011","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2013.03.038_bib21","doi-asserted-by":"crossref","first-page":"34654","DOI":"10.1074\/jbc.M111.276725","article-title":"Binding of autotaxin to integrins localizes lysophosphatidic acid production to platelets and mammalian cells","volume":"286","author":"Fulkerson","year":"2011","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2013.03.038_bib22","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/nsmb.1980","article-title":"Structural basis of substrate discrimination and integrin binding by autotaxin","volume":"18","author":"Hausmann","year":"2011","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.atherosclerosis.2013.03.038_bib23","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/nm.1870","article-title":"Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development","volume":"14","author":"Wilensky","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.atherosclerosis.2013.03.038_bib24","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.atherosclerosis.2012.02.010","article-title":"Lysophosphatidic acid causes endothelial dysfunction in porcine coronary arteries and human coronary artery endothelial cells","volume":"222","author":"Chen","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2013.03.038_bib25","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.cmet.2011.02.016","article-title":"Lipoprotein-derived lysophosphatidic acid promotes atherosclerosis by releasing CXCL1 from the endothelium","volume":"13","author":"Zhou","year":"2011","journal-title":"Cell Metab"},{"key":"10.1016\/j.atherosclerosis.2013.03.038_bib26","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1161\/CIRCRESAHA.109.212647","article-title":"Lysophosphatidic acid receptors LPA1 and LPA3 promote CXCL12-mediated smooth muscle progenitor cell recruitment in neointima formation","volume":"107","author":"Subramanian","year":"2010","journal-title":"Circ Res"},{"key":"10.1016\/j.atherosclerosis.2013.03.038_bib27","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1182\/blood-2003-04-1127","article-title":"The plaque lipid lysophosphatidic acid stimulates platelet activation and platelet-monocyte aggregate formation in whole blood: involvement of P2Y1 and P2Y12 receptors","volume":"103","author":"Haseruck","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.atherosclerosis.2013.03.038_bib28","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1161\/01.CIR.0000083715.37658.C4","article-title":"Subtype-selective antagonists of lysophosphatidic acid receptors inhibit platelet activation triggered by the lipid core of atherosclerotic plaques","volume":"108","author":"Rother","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2013.03.038_bib29","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/cvr\/cvq369","article-title":"GPR92\/LPA(5) lysophosphatidate receptor mediates megakaryocytic cell shape change induced by human atherosclerotic plaques","volume":"90","author":"Khandoga","year":"2011","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.atherosclerosis.2013.03.038_bib30","doi-asserted-by":"crossref","first-page":"17304","DOI":"10.1074\/jbc.M109.003194","article-title":"Unique ligand selectivity of the GPR92\/LPA5 lysophosphatidate receptor indicates role in human platelet activation","volume":"284","author":"Williams","year":"2009","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2013.03.038_bib31","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.jacc.2009.03.076","article-title":"The CD40\/CD40 ligand system: linking inflammation with atherothrombosis","volume":"54","author":"Antoniades","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2013.03.038_bib32","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1160\/TH03-05-0268","article-title":"Membrane-associated CD40L and sCD40L in atherothrombotic disease","volume":"90","author":"Anand","year":"2003","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.atherosclerosis.2013.03.038_bib33","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1161\/hh2401.101272","article-title":"CD40 signaling and plaque instability","volume":"89","author":"Schonbeck","year":"2001","journal-title":"Circ Res"},{"key":"10.1016\/j.atherosclerosis.2013.03.038_bib34","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/clc.26","article-title":"Transcoronary concentration gradient of sCD40L and hsCRP in patients with coronary heart disease","volume":"30","author":"Wang","year":"2007","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.atherosclerosis.2013.03.038_bib35","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ijcard.2005.10.005","article-title":"Inflammatory and vasoactive factors in the aspirate from the culprit coronary artery of patients with acute myocardial infarction","volume":"112","author":"Ko","year":"2006","journal-title":"Int J Cardiol"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915013002141?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915013002141?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T18:51:58Z","timestamp":1562957518000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915013002141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S0021915013002141"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2013.03.038","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased lysophosphatidic acid levels in culprit coronary arteries of\u00a0patients with acute coronary syndrome","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2013.03.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}